Vera Therapeutics, Inc. (VERA)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.24B |
| Enterprise Value | 1.89B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.34 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.60 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.11 |
| 52-Week Change 3 | 408.56% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 50.78 |
| 52 Week Low 3 | 7.10 |
| 50-Day Moving Average 3 | 41.95 |
| 200-Day Moving Average 3 | 25.81 |
Share Statistics
| Avg Vol (3 month) 3 | 979.56k |
| Avg Vol (10 day) 3 | 626.93k |
| Shares Outstanding 5 | 54.7M |
| Implied Shares Outstanding 6 | 54.7M |
| Float 8 | 36.11M |
| % Held by Insiders 1 | 7.91% |
| % Held by Institutions 1 | 104.30% |
| Shares Short (Apr 30, 2024) 4 | 6.8M |
| Short Ratio (Apr 30, 2024) 4 | 5.57 |
| Short % of Float (Apr 30, 2024) 4 | 18.49% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 12.50% |
| Shares Short (prior month Mar 28, 2024) 4 | 6.33M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -20.25% |
| Return on Equity (ttm) | -36.89% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -94.3M |
| Diluted EPS (ttm) | -2.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 403.66M |
| Total Cash Per Share (mrq) | 7.38 |
| Total Debt (mrq) | 53.26M |
| Total Debt/Equity (mrq) | 15.06% |
| Current Ratio (mrq) | 28.63 |
| Book Value Per Share (mrq) | 6.49 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -99.72M |
| Levered Free Cash Flow (ttm) | -72.91M |
© 2024 Yahoo. All rights reserved.